|
|
 |
|
Viewing report
|
|
|
|
Abbott Diagnostics - Product Pipeline Analysis
GlobalData, March 2012, Pages: 100
Abbott Diagnostics - Product Pipeline Analysis
Summary
Abbott Diagnostics is one of the world’s leading in vitro diagnostics company that offers a wide range of innovative instrument, tests and systems for clinics and hospitals. The company develops, manufactures and supplies products for in-vitro diagnostics market. Its products are used in diagnosing various health issues, such as rheumatoid arthritis, HIV/AIDS, respiratory infections, cancer, diabetes, men's and women's health, and genetic conditions. Abbott Diagnostics offer products in key categories namely, Immunoassay and Clinical Chemistry, Hematology, Molecular Diagnostics, and Point of Care. It has a customer base of 69,000 institutional customers in more than 100 countries.
This report is a source for data, analysis and actionable intelligence on the Abbott Diagnostics portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Customers who bought this item also bought
Abbott Laboratories (ABT) - Product Pipeline Analysis
Neogenix Oncology, Inc. - Product Pipeline Analysis
Nanosphere, Inc. (NSPH) - Product Pipeline Analysis
ARK Diagnostics, Inc. - Product Pipeline Analysis
Roche Diagnostics Limited - Product Pipeline Analysis
Biomoda, Inc. (BMOD) - Product Pipeline Analysis
Oryzon Genomics - Product Pipeline Analysis
Becton, Dickinson and Company (BDX) - Product Pipeline Analysis
Protagen AG - Product Pipeline Analysis
Ortho-Clinical Diagnostics Inc. - Product Pipeline Analysis
|
|
|
|
